Prof. Renee Elise Shellum, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 735 E Pearl St, Kasota, MN 56050 Phone: 507-382-2194 |
News Archive
QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), announced today that the United States Food and Drug Administration (FDA) has accepted the Investigational New Drug application (IND) to begin human clinical trials and evaluate the safety and efficacy of the company's second product, bisnorcymserine (BNC).
The House Ways and Means Committee on Wednesday by voice vote unanimously approved a bill (HR 493) that would ban discrimination against U.S. residents based on the results of genetic tests, CongressDaily reports.
The link between obesity and high-risk pregnancies caused by preeclampsia and diabetes will be the focus of a $2.4 million National Institutes of Health research grant received by Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston.
Workers who have diabetes with neuropathic symptoms such as numbness or tingling in feet or hands lose the equivalent of 1.4 hours a week or $3.65 billion per year in health-related lost productive time, a recent study finds.
Researchers are currently recruiting patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. People who are having symptoms after experiencing a traumatic event or who have been diagnosed with PTSD may be eligible to participate in this study of a new investigational drug.
› Verified 7 days ago